Technology>PSMEL®

PSMEL®

PSMEL® comprises large libraries of small-drug-like molecules spanning diverse disease areas and corresponding targets for therapeutic intervention.

The libraries are generated by the process known as IGSME® (In Silico Generation of Small Molecular Entities) which includes expert analysis of patents and journals and the use of highly advanced software. The libraries also include high quality data sets. Compounds in the libraries are screened by our Chemoinformatic tools, revealing that they may interact with multiple targets or pathways and produce more than one therapeutic outcome.

Applications

  • Comprehensive studies with our Chemoinformatic tools
  • Design of new drug-like molecules interacting with multiple targets
  • Studies of patentability of new bioactive molecules
  • Identification and optimization of drug scaffolds

The diagram below illustrates how PSMEL® is organized in a type 2 diabetes drug R&D project, covering 46 targets (partial list provided below):